Literature DB >> 3121405

Chain-fluorinated polyamines as tumor markers--I. In vivo transformation of 2,2-difluoroputrescine into 6,6-difluorospermidine and 6,6-difluorospermine.

S Sarhan1, B Knodgen, F Gerhart, N Seiler.   

Abstract

1. Injection of 2,2-difluoroputrescine (DFPut) into the yolk sac of chick embryos causes the formation of 6,6-difluorospermidine (6,6DFSpd) and 6,6-difluorospermine (6,6DFSpm), demonstrating that the difluoroanalogs of putrescine and spermidine are in vivo substrates of spermidine and spermine synthase, respectively. 2. Depletion of tissue putrescine and spermidine concentrations by administration of D,L-alpha-difluoromethylornithine (DFMO, Ornidyl) causes a very marked enhancement of difluoropolyamine formation from DFPut. 3. The major accumulation of 6,6DFSpd and 6,6DFSpm in DFMO-pretreated rodents occurs in small intestines and tumors, i.e. in tissues with high cell proliferation rates, which are also the most susceptible to polyamine depletion by inhibition of ornithine decarboxylase. 4. Their preferential accumulation in tumors and the fact that DFPut and its metabolites seem not to exert toxic effects, suggest DFPut as a serious candidate for the use as probe in 19F-NMR imaging of tissues with a high proliferation rate and a high rate of polyamine biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3121405     DOI: 10.1016/0020-711x(87)90244-8

Source DB:  PubMed          Journal:  Int J Biochem        ISSN: 0020-711X


  6 in total

Review 1.  Current status of the polyamine research field.

Authors:  Anthony E Pegg; Robert A Casero
Journal:  Methods Mol Biol       Date:  2011

2.  Enhanced uptake of [3H] spermidine by 9L rat brain tumors after direct intratumoral infusion of inhibitors of enzymes of the polyamine biosynthetic pathway.

Authors:  E S Redgate; A G Grudziak; M Deutsch; S S Boggs
Journal:  J Neurooncol       Date:  1999-04       Impact factor: 4.130

3.  Role of unsaturated derivatives of spermidine as substrates for spermine synthase and in supporting growth of SV-3T3 cells.

Authors:  A E Pegg; S Nagarajan; S Naficy; B Ganem
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

Review 4.  Polyamines in brain tumor therapy.

Authors:  E S Redgate; S Boggs; A Grudziak; M Deutsch
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

5.  Studies of non-metabolizable polyamines that support growth of SV-3T3 cells depleted of natural polyamines by exposure to alpha-difluoromethylornithine.

Authors:  S Nagarajan; B Ganem; A E Pegg
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

6.  Chain-fluorinated polyamines as tumor markers. II. Metabolic aspects in normal tissues.

Authors:  N Seiler; S Sarhan; B Knödgen; F Gerhart
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.